Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas-ko ikertzaileekin lankidetzan egindako argitalpenak (7)

2010

  1. Deficiency in p53 but not retinoblastoma induces the transformation of mesenchymal stem cells in vitro and initiates leiomyosarcoma in vivo

    Cancer Research, Vol. 70, Núm. 10, pp. 4185-4194

2006

  1. Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease

    Stem Cells, Vol. 24, Núm. 11, pp. 2582-2591

2005

  1. Tumor cells as cellular vehicles to deliver gene therapies to metastatic tumors

    Cancer Gene Therapy, Vol. 12, Núm. 4, pp. 341-349

2003

  1. Purging of leukemia-contaminated bone marrow grafts using suicide adenoviral vectors: An in vivo murine experimental model

    Gene Therapy, Vol. 10, Núm. 16, pp. 1328-1335

2002

  1. Efficient and nontoxic adenoviral purging method for autologous transplantation in breast cancer patients

    Cancer Research, Vol. 62, Núm. 17, pp. 5013-5018

2001

  1. Selective transduction of murine myelomonocytic leukemia cells (WEHI-3B) with regular and RGD-adenoviral vectors

    Molecular Therapy, Vol. 3, Núm. 1, pp. 70-77

2000

  1. Transplantation of syngenic bone marrow contaminated with NCFr-marked WEHI-3B cells: An improved model of leukemia relapse in mice

    Leukemia, Vol. 14, Núm. 3, pp. 457-465